LSA
ADPT icon

Leonteq Securities AG’s Adaptive Biotechnologies ADPT Stock Holding History

Leonteq Securities AG’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,000
Closed -$84.2K – 1243
2021
Q4 		$84.2K Sell
3,000
-2,000
-40% -$61.3K ﹤0.01% 808
2021
Q3 		$170K Sell
5,000
-1,500
-23% -$54.3K 0.01% 621
2021
Q2 		$266K Buy
6,500
+887
+16% +$34.5K 0.02% 516
2021
Q1 		$226K Buy
5,613
+613
+12% +$33.2K 0.01% 529
2020
Q4 		$296K Buy
+5,000
New +$258K 0.02% 507

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Leonteq Securities AG's ADPT Position: Q1 2022 in Review

Leonteq Securities AG sold out of Adaptive Biotechnologies (ADPT) in Q1 2022, closing a stake of 3,000 shares — an estimated $84.2K sold.

Leonteq Securities AG first reported a position in ADPT in Q4 2020 and held it in 5 quarters. The position peaked at $296K in Q4 2020. 221 funds tracked by Wall St. Rank hold ADPT as of Q1 2022.

  • Leonteq Securities AG reported no remaining Adaptive Biotechnologies position as of Q1 2022 after selling out during the quarter.
  • Leonteq Securities AG sold 3,000 Adaptive Biotechnologies shares in Q1 2022, an estimated $84.2K.
  • Leonteq Securities AG first reported a position in Adaptive Biotechnologies in Q4 2020 and held it in 5 quarters.
  • Leonteq Securities AG's Adaptive Biotechnologies position peaked at $296K in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2022.

Based on Leonteq Securities AG's 13F filing for Q1 2022, filed 26 Mar 2026.